SEC Form 4 · accession 0001179110-18-002372
Inotiv, Inc. · NOTVQ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip A Downing
Officer — Sr. VP, Preclinical Srvcs.
Period of report
Feb 16, 2018
Accepted (ET)
Feb 20, 2018 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000720154
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Feb 16, 2018 | P | 5,000 | $1.46 | A | 15,765 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in column 4 is a weighted average price. The shares sold were sold in multiple transactions at prices ranging from $1.45 to $1.4594, inclusive. The reporting person undertakes to provide Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.